This is consistent with our previous studies in which pretreatment with pemetrexed, a nucleotide synthesis inhibitor, further augmented chemo- and radiotherapy-induced H2AX phosphorylation, resulting in increased anti-cancer efficiency of the combination regimens33–35. The gene discussed is H2AX; the disease is cancer.